APIE Therapeutics Appoints Ashwin Datt Chief Executive Officer
Former CEO and Founder, Esther Alegria, Remains on Executive Team Focused on Driving Research & Development Through External Collaborations
APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
APIE Therapeutics appoints Robert Willette, Ph.D. to the newly created role of chief scientific officer.
